ImmunoPET to help stratify patients for targeted therapies and to improve drug development

Detalles Bibliográficos
Autores principales: Kraeber-Bodere, Françoise, Bailly, Clément, Chérel, Michel, Chatal, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047921/
https://www.ncbi.nlm.nih.gov/pubmed/27539021
http://dx.doi.org/10.1007/s00259-016-3458-6
_version_ 1782457498073038848
author Kraeber-Bodere, Françoise
Bailly, Clément
Chérel, Michel
Chatal, Jean-François
author_facet Kraeber-Bodere, Françoise
Bailly, Clément
Chérel, Michel
Chatal, Jean-François
author_sort Kraeber-Bodere, Françoise
collection PubMed
description
format Online
Article
Text
id pubmed-5047921
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-50479212016-10-18 ImmunoPET to help stratify patients for targeted therapies and to improve drug development Kraeber-Bodere, Françoise Bailly, Clément Chérel, Michel Chatal, Jean-François Eur J Nucl Med Mol Imaging Editorial Commentary Springer Berlin Heidelberg 2016-08-18 2016 /pmc/articles/PMC5047921/ /pubmed/27539021 http://dx.doi.org/10.1007/s00259-016-3458-6 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Editorial Commentary
Kraeber-Bodere, Françoise
Bailly, Clément
Chérel, Michel
Chatal, Jean-François
ImmunoPET to help stratify patients for targeted therapies and to improve drug development
title ImmunoPET to help stratify patients for targeted therapies and to improve drug development
title_full ImmunoPET to help stratify patients for targeted therapies and to improve drug development
title_fullStr ImmunoPET to help stratify patients for targeted therapies and to improve drug development
title_full_unstemmed ImmunoPET to help stratify patients for targeted therapies and to improve drug development
title_short ImmunoPET to help stratify patients for targeted therapies and to improve drug development
title_sort immunopet to help stratify patients for targeted therapies and to improve drug development
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047921/
https://www.ncbi.nlm.nih.gov/pubmed/27539021
http://dx.doi.org/10.1007/s00259-016-3458-6
work_keys_str_mv AT kraeberboderefrancoise immunopettohelpstratifypatientsfortargetedtherapiesandtoimprovedrugdevelopment
AT baillyclement immunopettohelpstratifypatientsfortargetedtherapiesandtoimprovedrugdevelopment
AT cherelmichel immunopettohelpstratifypatientsfortargetedtherapiesandtoimprovedrugdevelopment
AT chataljeanfrancois immunopettohelpstratifypatientsfortargetedtherapiesandtoimprovedrugdevelopment

Ejemplares similares